Virtual Reality Versus Intravenous Dexmedetomidine on Maternal Anxiety, Stress, Hemodynamics, and Neonatal Outcomes During Cesarean Section

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18+
SponsorBenha University

About this trial

This study aims to compare the efficacy of intravenous dexmedetomidine infusion versus virtual reality (VR) in reducing maternal anxiety, stress, and hemodynamic instability during cesarean section and their effects on neonatal outcome as respiration and heart rate.

Eligibility criteria

Qualifiers

Age over 18 years old.

American Society of Anesthesiologists (ASA) physical status II.

Scheduled for elective cesarean section (CS) delivery under Central Neuraxial Blockade.

Provide informed consent and agree to participate in the study.

Disqualifiers

Patient's refusal

Patient known have contraindications for Regional Anesthesia as infection at the site of injection, severe coagulopathy or allergy to local anesthetics.

Patient with psychiatric disorders.

Sensory impairment (blindness, deafness).

Trial design

Treatments tested in this trial

  • Dexmedetomidine
  • Virtual reality

Treatment groups

52 Participants
are divided into 2 treatment groups

Sponsors and collaborators